Filing Details

Accession Number:
0001209191-14-012279
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-20 15:27:52
Reporting Period:
2013-09-24
Filing Date:
2014-02-20
Accepted Time:
2014-02-20 15:27:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1399529 Dicerna Pharmaceuticals Inc DRNA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1259856 Douglas Fambrough C/O Dicerna Pharmaceuticals, Inc.
480 Arsenal Street, Bldg 1, Suite 120
Watertown MA 02472
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-11-11 9,300 $3.42 12,300 No 4 M Direct
Common Stock Acquisiton 2014-01-29 5,000 $15.00 17,300 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2013-11-11 4,950 $0.00 4,950 $3.42
Common Stock Employee Stock Option (right to buy) Disposition 2013-11-11 4,350 $0.00 4,350 $3.42
Common Stock Employee Stock Option (right to buy) Acquisiton 2013-09-24 281,250 $0.00 281,250 $3.42
Common Stock Employee Stock Option (right to buy) Acquisiton 2013-09-24 281,250 $0.00 281,250 $3.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,050 2020-06-08 No 4 M Direct
1,450 2020-10-14 No 4 M Direct
281,250 2023-09-24 No 4 A Direct
281,250 2023-09-24 No 4 A Direct
Footnotes
  1. 20% vests 05/06/2011 and 20% vests on last day of month for 12 months thereafter. Remaining 60% vests over 24 months thereafter on last day of month.
  2. 20% vests on 08/05/2011 and 20% vests in installments on 5th day of month for 12 months thereafter. Remaining 60% vests over 24 months thereafter.
  3. The vesting of this option is subject to achievement of pre-established performance goals.
  4. Vests 1/48 monthly on last day of each month with a vesting start date of 07/30/2013.